TriSalus Life Sciences
TLSI
TLSI
48 hedge funds and large institutions have $46.8M invested in TriSalus Life Sciences in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
12.64% more ownership
Funds ownership: 10.06% → 22.7% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$10.7M | |
| 2 | +$6.71M | |
| 3 | +$3.17M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.99M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
Top Sellers
| 1 | -$553K | |
| 2 | -$147K | |
| 3 | -$112K | |
| 4 |
Goldman Sachs
New York
|
-$91.6K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$78.4K |